The concussion market has seen considerable growth due to a variety of factors.
•Over the past few years, the concussion market size has seen consistent growth. It is set to expand from $7.97 billion in 2024 to $8.22 billion in 2025, with a compound annual growth rate (CAGR) of 3.3%.
The growth seen in the past can be tied back to increased education and awareness, an increase in sports participation and related injuries, strict sports regulations, improvements in diagnostic tools, along with legal and ethical impacts.
The concussion market is expected to maintain its strong growth trajectory in upcoming years.
• Steady escalation is expected in the concussion market size in the upcoming years. It is predicted to reach up to $9.94 billion by the year 2029, exibiting a compound annual growth rate (CAGR) of 4.9%.
The factors contributing to this growth in the projected period are the persistent emphasis on safety in sports, development in research and treatment, increased implementation of concussion procedures, rising awareness of public health and alliance between medical and sports communities. The substantial trends within the forecast frame includes teleconcussion services and distant monitoring, knowledge initiatives to avoid concussions, studies on long-term impacts and chronic traumatic encephalopathy (CTE), the implementation of concussion guidelines in sports bodies, introduction of neuroprotective treatments, and laws and regulation formulated for the management of concussion.
The concussion market is expected to grow in tandem with the rising incidence of brain injuries. These injuries, which indicate any form of damage that impacts the brain, can cause an array of physical, cognitive, and emotional challenges. Effective and early concussion treatment can mitigate the effects of such injuries on general brain health. This can be achieved through physical and cognitive rest, managing symptoms, and a gradual resumption of activities. An uptick in traffic accidents has also contributed to increased brain injuries. For example, in January 2023, the National Center for Biotechnology Information reported that, every year in the US, around 1.7 million people suffer traumatic brain injuries. Those aged 15 to 19 and above 65 are most at risk. Then in March 2023, the American Society of Clinical Oncology predicted that primary malignant tumors of the brain and spine will impact 24,810 people (14,280 men and 10,530 women) in the US in 2020. Additionally, brain tumors constitute 85% to 90% of all these cases. Consequently, the escalating prevalence of brain injuries is fueling the expansion of the concussion market.
The concussion market covered in this report is segmented –
1) By Assessment: Diagnosis, Treatment
2) By Device: Imaging Devices, Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Monitoring Devices, Other Devices
3) By End User: Hospitals And Clinics, Diagnostic Centers, Medical Camps, Other End-Users
Subsegments:
1) By Diagnosis: Clinical Assessments, Imaging Techniques
2) By Treatment: Pharmacological Treatments, Cognitive Rehabilitation, Physical Therapy
In the concussion market, product innovation has emerged as the leading trend. The major companies participating in this market are heavily focusing on creating innovative products to enhance their observatory capabilities and maintain their stand. For instance, in May 2022, TecTraum Inc., an American medical device creator and developer, along with Nottingham-Spirk Design Associates Inc., another U.S.-based product design firm, launched pro2cool. This invention claims to be the first-of-its-kind at-the-point-of-care treatment for concussions and is hailed as the inaugural medical device therapy for these head injuries. The pro2cool mechanism introduces a game-changing, non-invasive freezing treatment intended to respond swiftly to alleviate the effects of concussion symptoms and accelerate patient recovery to their pre-injury state. The tool functions by cooling the head and neck just enough to reduce the blood temperature before it enters the brain. Earlier clinical research suggests that cooling the brain within some days after a concussion could produce considerable enhancements in patient outcomes.
Major companies operating in the concussion market include:
• Pfizer Inc.
• Novartis AG
• Sanofi SA
• Abbott Laboratories
• Medtronic plc
• Viatris Inc.
• Zydus Lifesciences Ltd.
• Integra LifeSciences Corporation
• Nihon Kohden Corporation
• Raumedic AG
• Lupin Limited
• NeuroPace Inc.
• Compumedics Limited
• NeuroLogica Corporation
• Neural Analytics Inc.
• NovaSignal Corp.
• Back Bay Life Science Advisors
• BrainScope Company Inc.
• Neuro Kinetics Inc.
• ImPACT Applications Inc.
• NanoDx Inc.
• Neuren Pharmaceuticals Limited
• Advanced Brain Monitoring Inc.
• ElMindA Ltd.
• NeurOptics Inc.
• InfraScan Inc.
• Neuro Assessment Systems Inc.
• NeuroTrauma Sciences LLC
• SyncThink Inc.
• Oxeia Biopharmaceuticals Inc.
• Oculogica Inc.
• Banyan Biomarkers Inc.
• Emotiv Inc.
• BioDirection Inc.
• Neurologic Wellness Institute
North America was the largest region in the concussion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the concussion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.